Evidence map›Paper›PMID 33709162›Full record

ArticleInternational journal of colorectal disease2021

The Italian version of the LARS score: cross-cultural adaptation and validation. An Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CCN) collaborative study.

Aridai Resendiz, Giulia Martini, Bruno Sensi, Rossella Reddavid, Giulia Marchiori, Caterina Franco, Marzia Franceschilli, Natalia Imperio, Giuseppe Sica, Gaya Spolverato and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Aridai ResendizDepartment of Oncology, Surgical Oncology and Digestive Surgery Unit, S Luigi University Hospital, University of Turin, Regione Gonzole 10, 10043, Orbassano, Turin, Italy.
Giulia MartiniDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Bruno SensiDepartment of Surgical Science, Minimally Invasive and GI Unit, Tor Vergata University Hospital, Rome, Italy.
Rossella ReddavidDepartment of Oncology, Surgical Oncology and Digestive Surgery Unit, S Luigi University Hospital, University of Turin, Regione Gonzole 10, 10043, Orbassano, Turin, Italy.
Giulia MarchioriDepartment of Oncology, Surgical Oncology and Digestive Surgery Unit, S Luigi University Hospital, University of Turin, Regione Gonzole 10, 10043, Orbassano, Turin, Italy.
Caterina FrancoDepartment of Oncology, Surgical Oncology and Digestive Surgery Unit, S Luigi University Hospital, University of Turin, Regione Gonzole 10, 10043, Orbassano, Turin, Italy.
Marzia FranceschilliDepartment of Surgical Science, Minimally Invasive and GI Unit, Tor Vergata University Hospital, Rome, Italy.
Natalia ImperioDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Giuseppe SicaDepartment of Surgical Science, Minimally Invasive and GI Unit, Tor Vergata University Hospital, Rome, Italy.
Gaya SpolveratoDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Maurizio DegiuliDepartment of Oncology, Surgical Oncology and Digestive Surgery Unit, S Luigi University Hospital, University of Turin, Regione Gonzole 10, 10043, Orbassano, Turin, Italy. maurizio.degiuli@unito.it.ORCID http://orcid.org/0000-0002-9812-7020
University of Turin · ITUniversity of Padua · ITUniversity of Rome Tor Vergata · ITOspedale San Luigi Gonzaga · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe LARS score is an internationally well-accepted questionnaire to assess low anterior resection syndrome, but currently there is no formally validated Italian version. The purpose of this study was to test the reliability and validity of the Italian version among Italian patients submitted to sphincter-sparing surgery for rectal cancer.

methodsThe English version of the LARS score was translated into Italian following the forward-and-back translation process. A total of 147 patients filled out our version. Among them, 40 patients answered the questionnaire twice for the test-retest reliability phase. The validity of the LARS score was tested using convergent and discriminant validity indicators by correlating the EORTC QLQ-C30 and QLQ-CR29 questionnaires. The LARS score capability to differentiate groups of patients with different demographic or clinical features was also assessed.

resultsThe test-retest reliability was excellent in 87.5% of patients, remained in the same LARS category in both tests. The convergent validity phase showed a relevant relationship of the LARS score with the EORTC domains, which was significant for 7 of 15 EORTC QLQ-C30 subscales, and for 14 of 29 EORTC QLQ-CR29 subscales. The LARS score was able to discriminate patients who received radiotherapy (p = 0.0026), TME vs. PME (p = 0.0060), tumour site at < 10 cm from the anal verge (p = 0.0030) and history of protective stoma (p < 0.0001).

conclusionThe Italian version of the LARS score is a valid and reliable tool for measuring LARS in Italian patients after SSS for rectal cancer.

Indexed as

Rectal NeoplasmsSurgical OncologyAnal CanalCross-Cultural ComparisonHumansItalyOrgan Sparing TreatmentsPostoperative ComplicationsPsychometricsQuality of LifeReproducibility of ResultsSurveys and QuestionnairesSyndromeBowel dysfunctionLARSLARS scoreLow anterior resection syndromeRectal cancer

Identifiers

PMID33709162
OpenAlexW3134985924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.